The assessment of antagonist potency under conditions of transient response kinetics
Data up to Jan 2025
Total Citations Per Year
Abstract
References (29)
A new generation of Ca2+ indicators with greatly improved fluorescence properties.
1985 • 21,873 citations
Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction
1973 • 12,522 citations
SOME QUANTITATIVE USES OF DRUG ANTAGONISTS
1959 • 3,948 citations
Muscarinic Receptors—Characterization, coupling and function
1993 • 1,264 citations
Operational models of pharmacological agonism
1983 • 1,062 citations
Pharmacologic Analysis of Drug Receptor Interaction
1988 • 936 citations
Binding, gating, affinity and efficacy: The interpretation of structure‐activity relationships for agonists and of the effects of mutating receptors
1998 • 880 citations
The margin of safety of neuromuscular transmission
1967 • 409 citations
Pharmacologic analysis of drug-receptor interaction
1995 • 255 citations
Pharmacological profile of valsartan: a potent, orally active, nonpeptide antagonist of the angiotensin II AT1‐receptor subtype
1993 • 254 citations
pAx AND COMPETITIVE DRUG ANTAGONISM
1949 • 247 citations
Assessing the distribution of parameters in models of ligand–receptor interaction: to log or not to log
1998 • 174 citations
Muscarinic receptor differentiation
1988 • 158 citations
Analysis of competitive agonist-antagonist interactions by nonlinear regression
1995 • 143 citations
Is prenalterol (H133/80) really a selective beta 1 adrenoceptor agonist? Tissue selectivity resulting from differences in stimulus-response relationships.
1980 • 121 citations
Agonist-antagonist interactions at angiotensin receptors: application of a two-state receptor model
1994 • 65 citations
Evidence that the apparent complexity of receptor antagonism by angiotensin II analogues is due to a reversible and syntopic action
1992 • 65 citations
On the unique binding and activating properties of xanomeline at the M1 muscarinic acetylcholine receptor.
1998 • 61 citations
Qualitative and quantitative assessment of relative agonist efficacy
1999 • 55 citations
Unsurmountable antagonism to 5-hydroxytryptamine in rat kidney results from pseudoirreversible inhibition rather than multiple receptors or allosteric receptor modulation.
1989 • 35 citations
Kinetic studies on the interaction of nonlabeled antagonists with the angiotensin II receptor
1995 • 25 citations
Promiscuous or heterogeneous muscarinic receptors in rat atria? I. Schild analysis with simple competitive antagonists
1990 • 22 citations
Antihistaminic and antimuscarinic effects of amitriptyline on guinea pig ileal electrolyte transport and muscle contractility in vitro.
1988 • 21 citations
M1 Muscarinic Receptors Stimulate Rapid and Prolonged Phases of Neuronal Nitric Oxide Synthase Activity: Involvement of Different Calcium Pools
1998 • 20 citations
Different apparent modes of inhibition of α2A-adrenoceptor by α2-adrenoceptor antagonists
1997 • 19 citations
Pseudo-noncompetitive antagonism of muscarinic receptor-mediated cyclic GMP formation and phosphoinositide hydrolysis by pirenzepine.
1988 • 18 citations
N, N-Diethy1-2-(1-pyridyl)ethylamine, a partial agonist for the histamine receptor in guinea pig ileum
1980 • 17 citations
Pseudo-Noncompetitive Antagonism of M1, M3, and M5Muscarinic Receptor-Mediated Ca2+Mobilization by Muscarinic Antagonists
1998 • 15 citations
Promiscuous or heterogeneous muscarinic receptors in rat atria? II. Antagonism of responses to carbachol by pirenzepine
1990 • 6 citations